2024.06 At a press conference during the Bio International Convention (BioUSA) in San Diego, John Rim, CEO of Samsung Biologics, underscored the efficiency of expanding production facilities in Korea over building or acquiring foreign factories. This strategic approach is driven by a surge in orders, necessitating an expansion of production capabilities. CEO John Rim announced that the fifth pla..